tag:blogger.com,1999:blog-11326364.post3449720736791962236..comments2024-03-27T03:58:43.402-04:00Comments on <center>CasesBlog - Medical and Health Blog</center>: Liraglutide as initial pharmacological therapy for type 2 diabetes mellitusUnknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-11326364.post-5796022315282349512009-03-04T08:35:00.000-05:002009-03-04T08:35:00.000-05:00Martin,I don't think the study focused on reductio...Martin,<BR/><BR/>I don't think the study focused on reduction of stroke, infarction, renal failure - in any case, a duration of 52 weeks would be too short to assess for those. Usually, it takes 5-10 years to assess for those complications prospectively. <BR/><BR/>Regarding your second point - 400 patients is a large study. Most of the rare events you mentioned show in post-market analysis.<BR/><BR/>I hope this helps.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-11326364.post-27403491874986306552009-03-04T07:37:00.000-05:002009-03-04T07:37:00.000-05:00No clinical endpoints tested (stroke, infarction, ...No clinical endpoints tested (stroke, infarction, renal failure...).<BR/>A study of <400 patients for one year doesn not give enough enformation on drug safety esp. rare events.Martinhttps://www.blogger.com/profile/13078597404766627102noreply@blogger.com